1058 YH32364 (ABL104), a Novel EGFR/4–1BB Bispecific Antibody Exhibits Potent Antitumor Efficacy with an Excellent Safety Profile
JOURNAL FOR IMMUNOTHERAPY OF CANCER(2022)
关键词
EGFR
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL FOR IMMUNOTHERAPY OF CANCER(2022)